You are here

Leadership

Executive Management Team

Scott Whitaker, President & Chief Executive Officer

JC Scott
, Chief Advocacy Officer 

Kenneth Mendez, Chief Revenue Officer

Jen Brearey,  Chief Finance Officer 

Janet Trunzo, Senior Executive Vice President, Technology & Regulatory Affairs

Andrew Fish, Chief Strategy Officer, AdvaMed; Executive Director, AdvaMedDx

Christopher L. White, Chief Operating Officer; General Counsel 

Donald May, Executive Vice President, Payment & Health Care Delivery Policy

Ralph F. Ives, Executive Vice President, Global Strategy & Analysis

Ashley W. Wittorf, Executive Director, AdvaMed Accel; Global Head, Investor Relations

For a list of AdvaMed's board of directors, click here.

Policy Agenda

AdvaMed’s Policy Agenda is based upon four pillars and facilitated by AdvaMed Staff:

  1. Technology and Regulatory- Strives to improve the regulatory environment for member companies including such efforts as 510(k) reform, reauthorization of Medical Device User Fee Act (MDUFA), postmarket surveillance and enforcement, and global harmonization.
  2. Payment and Health Policy- Influences health care delivery and reimbursement policies to facilitate access to medical products and payment supporting innovation and value creation.
  3. Global Strategy and Analysis- Focuses on health care, trade, and medical technology regulatory and reimbursement issues in leading and key emerging world markets, and through international organizations.
  4. Legal and Compliance- Advocates for a predictable legal environment and focuses on areas such as Physician Payments Sunshine, Intellectual Property, Ethics and Compliance, Vendor Access, and the Medical Device Tax.

The General Counsel’s Office also oversees certification to the AdvaMed Code of Ethics, which clarifies and distinguishes appropriate and inappropriate activity between health care professionals and MedTech company representatives.